Archived Newsletters

21. 02.18.19 -- Strategic Considerations In Drug Development
    2/18/2019
    02/18/19 Outsourced Pharma Newsletter
22. 02.14.19 -- Have You Anticipated API Formulation And Development Challenges?
    2/14/2019
    02/14/19 Outsourced Pharma Newsletter
23. 02.13.19 -- A Biopharma CEO's Revelation: "We Outsource, Therefore We Exist"
    2/13/2019
    02/13/19 Outsourced Pharma Newsletter
24. 02.07.19 -- Biomanufacturing Facility Design: Considerations For Capacity, Flexibility, And Forecasting
    2/7/2019
    02/07/19 Outsourced Pharma Newsletter
25. 02.06.19 -- The Biotech And The Behemoths
    2/6/2019
    02/06/19 Outsourced Pharma Newsletter
26. 02.05.19 -- Have You Optimized Your Biologic Drug Development Strategy?
    2/5/2019
    02/05/19 Outsourced Pharma Newsletter
27. 01.30.19 -- A Biotech's Guide To Selecting CDMOs: "35 Or 6 To 2"
    1/30/2019
    01/30/19 Outsourced Pharma Newsletter
28. 01.23.19 -- New Data And Analysis On Biopharma Capacity
    1/23/2019
    01/23/19 Outsourced Pharma Newsletter
29. 01.22.19 -- What's Your Strategy For Oral Solid Dosage Development?
    1/22/2019
    01/22/19 Outsourced Pharma Newsletter
30. 01.18.19 -- CDMO Spotlight: Parenteral Drug Product Development and Manufacturing
    1/18/2019
    01/18/19 Outsourced Pharma Newsletter